Enhanced renal vasoconstriction in rats fed essential fatty acid-deficient diet
- PMID: 6807110
- DOI: 10.1152/ajpheart.1982.243.1.H61
Enhanced renal vasoconstriction in rats fed essential fatty acid-deficient diet
Abstract
The effects of angiotensin II (ANG II) and norepinephrine (NE) on total renal blood flow (RBF) were studied in rats fed an essential fatty acid (EFA)-deficient diet. EFA deficiency was employed, as an alternative to the use of cyclooxygenase inhibitors, to investigate the influence of arachidonic acid metabolites on rat RBF. Intrarenal arterial (ira) bolus doses of ANG II (2-16 ng) and NE (25-100 ng) elicited significantly greater decrements in RBF and increments in renal vascular resistance in anesthetized Sprague-Dawley rats fed EFA-deficient diets than in control rats, which were fed EFA-adequate diets. Indomethacin (5 mg/kg iv) enhanced the vasoconstrictor responses to ANG II and NE in rats fed the EFA-adequate diet but not in rats fed the EFA-deficient diet. In rats fed regular laboratory chow the renal vasoconstrictor response to ANG II was potentiated after the administration of either indomethacin or naproxen (5 mg/kg iv). Methacholine and prostaglandins E2 and I2 caused dose-related renal vasodilatation when injected (ira) over the dose range of 10-40 ng in rats fed either the EFA-deficient or -adequate diets. The increased responsiveness of the renal vascular bed to ANG II and NE in rats fed EFA-deficient diets was not attributable to reduced vasodilator efficacy. Collectively, these results suggest that the net effect of endoperoxide products of arachidonic acid metabolism attenuates the vasoconstrictor influences of exogenous ANG II and NE in the intact rat kidney.
Similar articles
-
Attenuation by arachidonic acid of the effect of vasoconstrictor stimuli in the canine kidney.J Pharmacol Exp Ther. 1981 Nov;219(2):377-82. J Pharmacol Exp Ther. 1981. PMID: 6793715
-
ADP-ribosyl cyclase and ryanodine receptor activity contribute to basal renal vasomotor tone and agonist-induced renal vasoconstriction in vivo.Am J Physiol Renal Physiol. 2007 Oct;293(4):F1107-14. doi: 10.1152/ajprenal.00483.2006. Epub 2007 Jul 25. Am J Physiol Renal Physiol. 2007. PMID: 17652368
-
Inhibition by bradykinin of renal adrenergic effects in anesthetized rats.Am J Physiol. 1984 Apr;246(4 Pt 2):F387-94. doi: 10.1152/ajprenal.1984.246.4.F387. Am J Physiol. 1984. PMID: 6426309
-
Moderate intrarenal vasoconstriction after high pressor doses of norepinephrine in the rat: comparison with effects of angiotensin II.Kidney Blood Press Res. 2011;34(5):307-10. doi: 10.1159/000328328. Epub 2011 May 23. Kidney Blood Press Res. 2011. PMID: 21606652
-
Essential fatty acids and immune response.FASEB J. 1989 Jul;3(9):2052-61. doi: 10.1096/fasebj.3.9.2501132. FASEB J. 1989. PMID: 2501132 Review.
Cited by
-
Urinary prostaglandin E2 and vasopressin excretion in essential fatty acid-deficient rats: effect of linolenic acid supplementation.Lipids. 1983 Oct;18(10):682-90. doi: 10.1007/BF02534534. Lipids. 1983. PMID: 6318006
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous